Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer

NCT00275951 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Taiwan University Hospital

Collaborators